Sovereign Health Pathways An Australian Model for Essential Medicines Procurement Regional Application: Southeast Asia, Oceania, and Papua New Guinea

The WHO Essential Medicines List exists because health is recognised internationally as the foundation upon which all other development rests. When communities are free from preventable parasitic disease, infectious illness, and treatable conditions, they can pursue education, economic participation, and self-determination. Australia has developed a system that delivers these essential medicines efficiently to some of the most remote communities on Earth. This is not a theoretical proposition—it is a working model, refined over decades, that achieves near-commodity pricing for off-patent medicines while maintaining quality assurance and community-controlled distribution. Sharing this expertise with partner nations across Southeast Asia, Oceania, and Papua New Guinea is an expression of regional solidarity—and a recognition that sustainable health systems benefit everyone, including the pharmaceutical industry whose innovative products require fiscally viable health budgets to reach patients.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-01-12
DOI
https://doi.org/10.5281/zenodo.18217216
Primary Topic
Pharmaceutical Quality and Counterfeiting
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sovereign Health Pathways An Australian Model for Essential Medicines Procurement Regional Application: Southeast Asia, Oceania, and Papua New Guinea

John R. Smith, HATI
Zenodo (CERN European Organization for Nuclear Research)
Pharmaceutical Quality and Counterfeiting
article

Sovereign Health Pathways An Australian Model for Essential Medicines Procurement Regional Application: Southeast Asia, Oceania, and Papua New Guinea

John R. Smith, HATI
article en

Abstract

The WHO Essential Medicines List exists because health is recognised internationally as the foundation upon which all other development rests. When communities are free from preventable parasitic disease, infectious illness, and treatable conditions, they can pursue education, economic participation, and self-determination. Australia has developed a system that delivers these essential medicines efficiently to some of the most remote communities on Earth. This is not a theoretical proposition—it is a working model, refined over decades, that achieves near-commodity pricing for off-patent medicines while maintaining quality assurance and community-controlled distribution. Sharing this expertise with partner nations across Southeast Asia, Oceania, and Papua New Guinea is an expression of regional solidarity—and a recognition that sustainable health systems benefit everyone, including the pharmaceutical industry whose innovative products require fiscally viable health budgets to reach patients.

Zenodo (CERN European Organization for Nuclear Research)
Capgemini (Netherlands) (NL)
Partnerships for the goals
Openalex Percentile: Top 91%
Pharmaceutical Quality and Counterfeiting
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.